Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (10): 1068-1074.doi: 10.3969/j.issn.1000-6621.2020.10.011
• Original Articles • Previous Articles Next Articles
YU Gang, HU Xiao-guang, LIN Li, LYU Fang-fang, LI Chang-chong, ZHANG Hai-lin()
Received:
2020-05-14
Online:
2020-10-10
Published:
2020-10-15
Contact:
ZHANG Hai-lin
E-mail:zhlwz97@hotmail.com
YU Gang, HU Xiao-guang, LIN Li, LYU Fang-fang, LI Chang-chong, ZHANG Hai-lin. A cross-sectional survey of the awareness of pediatric medical personnel on tuberculosis prevention and control in Zhejiang province[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1068-1074. doi: 10.3969/j.issn.1000-6621.2020.10.011
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.10.011
特征 | 三级甲等 | 三级乙等 | 二级甲等 | 二级乙等 | 其他b | 总计 |
---|---|---|---|---|---|---|
职称 | ||||||
主任医师 | 29(6.92) | 35(12.54) | 41(11.61) | 3(3.45) | 4(6.56) | 112(9.34) |
副主任医师 | 77(18.38) | 55(19.71) | 51(14.45) | 17(19.54) | 11(18.03) | 211(17.60) |
主治医师 | 117(27.92) | 58(20.79) | 73(20.68) | 25(28.74) | 19(31.15) | 292(24.35) |
住院医师 | 70(16.71) | 48(17.20) | 57(16.15) | 12(13.79) | 10(16.39) | 197(16.43) |
其他a | 126(30.07) | 83(29.75) | 131(37.11) | 30(34.48) | 17(27.87) | 387(32.28) |
专业 | ||||||
临床医生 | 294(70.17) | 193(69.18) | 222(62.89) | 58(66.67) | 48(78.69) | 815(67.97) |
护理人员 | 125(29.83) | 86(30.82) | 131(37.11) | 29(33.33) | 13(21.31) | 384(32.03) |
地区 | ||||||
温州市 | 192(45.83) | 53(19.00) | 37(10.49) | 7(8.04) | 11(18.03) | 300(25.01) |
宁波市 | 33(7.88) | 60(21.50) | 35(9.92) | 9(10.34) | 21(34.42) | 158(13.18) |
湖州市 | 7(1.67) | 39(13.98) | 51(14.45) | 23(26.44) | 5(8.19) | 125(10.43) |
嘉兴市 | 35(8.35) | 33(11.83) | 40(11.33) | 8(9.20) | 7(11.48) | 123(10.26) |
丽水市 | 30(7.16) | 1(0.36) | 71(20.11) | 16(18.39) | 1(1.64) | 119(9.92) |
金华市 | 4(0.95) | 38(13.62) | 42(11.90) | 12(13.79) | 2(3.28) | 98(8.17) |
台州市 | 16(3.82) | 29(10.39) | 38(10.76) | 3(3.45) | 7(11.48) | 93(7.76) |
杭州市 | 65(15.51) | 8(2.87) | 6(1.70) | 0(0.00) | 5(8.20) | 84(7.01) |
衢州市 | 3(0.72) | 11(3.94) | 28(7.93) | 7(8.05) | 1(1.64) | 50(4.17) |
舟山市 | 21(5.01) | 1(0.36) | 4(1.13) | 2(2.30) | 1(1.64) | 29(2.42) |
绍兴市 | 13(3.10) | 6(2.15) | 1(0.28) | 0(0.00) | 0(0.00) | 20(1.67) |
总计 | 419(34.95) | 279(23.27) | 353(29.44) | 87(7.26) | 61(5.08) | 1199(100.00) |
调查问题 | 医院等级 | 职称 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
三级 | 二级 | 其他a | 高级 | 中级 | 初级 | 其他b | χ2值 | P值 | ||||||||||
WHO提出结核病终结策略 | 2.133 | 0.344 | ||||||||||||||||
知道 | 104 (14.90) | 61 (13.86) | 8 (13.11) | 48 (14.86) | 43 (14.73) | 25 (12.69) | 57 (14.73) | |||||||||||
有了解 | 360 (51.58) | 253 (57.50) | 34 (55.74) | 194 (60.06) | 164 (56.16) | 112 (56.85) | 177 (45.74) | |||||||||||
不知道 | 234 (33.52) | 126 (28.64) | 19 (31.15) | 81 (25.08) | 85 (29.11) | 60 (30.46) | 153 (39.53) | |||||||||||
WHO全球结核病报告 | 5.203 | 0.074 | ||||||||||||||||
知道 | 88 (12.61) | 52 (11.82) | 8 (13.12) | 38 (11.76) | 40 (13.70) | 19 (9.64) | 51 (13.18) | |||||||||||
有了解 | 341 (48.85) | 228 (51.82) | 26 (42.62) | 187 (57.90) | 151 (51.71) | 99 (50.25) | 158 (40.83) | |||||||||||
不知道 | 269 (38.54) | 160 (36.36) | 27 (44.26) | 98 (30.34) | 101 (34.59) | 79 (40.11) | 178 (45.99) | |||||||||||
WHO潜伏结核感染预防策略文件 | 3.313 | 0.191 | ||||||||||||||||
知道 | 80 (11.46) | 51 (11.59) | 5 (8.20) | 36 (11.15) | 27 (9.25) | 18 (9.14) | 55 (14.21) | |||||||||||
有了解 | 333 (47.71) | 208 (47.27) | 28 (45.90) | 166 (51.39) | 156 (53.42) | 91 (46.19) | 156 (40.31) | |||||||||||
不知道 | 285 (40.83) | 181 (41.14) | 28 (45.90) | 121 (37.46) | 109 (37.33) | 88 (44.67) | 176 (45.48) | |||||||||||
世界结核病防治日 | 1.955 | 0.376 | ||||||||||||||||
知道 | 206 (29.51) | 165 (37.50) | 26 (42.62) | 103 (31.89) | 102 (34.93) | 63 (31.98) | 129 (33.33) | |||||||||||
有了解 | 294 (42.12) | 167 (37.95) | 21 (34.43) | 129 (39.94) | 120 (41.10) | 77 (39.09) | 156 (40.31) | |||||||||||
不知道 | 198 (28.37) | 108 (24.55) | 14 (22.95) | 91 (28.17) | 70 (23.97) | 57 (28.93) | 102 (26.36) | |||||||||||
《WS 196—2017 结核病分类》 | 1.417 | 0.492 | ||||||||||||||||
知道 | 86 (12.32) | 63 (14.32) | 6 (9.84) | 35 (10.84) | 39 (13.36) | 29 (14.72) | 52 (13.44) | |||||||||||
有了解 | 256 (36.68) | 150 (34.09) | 24 (39.34) | 123 (38.08) | 114 (39.04) | 64 (32.49) | 129 (33.33) | |||||||||||
不知道 | 356 (51.00) | 227 (51.59) | 31 (50.82) | 165 (51.08) | 139 (47.60) | 104 (52.79) | 206 (53.23) | |||||||||||
《WS 288—2017 肺结核诊断》 | 4.244 | 0.12 | ||||||||||||||||
知道 | 88 (12.61) | 67 (15.23) | 4 (6.56) | 40 (12.38) | 40 (13.70) | 26 (13.20) | 159 (13.70) | |||||||||||
有了解 | 284 (40.69) | 173 (39.32) | 24 (39.34) | 129 (39.94) | 136 (46.57) | 80 (40.61) | 136 (35.14) | |||||||||||
不知道 | 326 (46.70) | 200 (45.45) | 33 (54.10) | 154 (47.68) | 116 (39.73) | 91 (46.19) | 198 (51.16) | |||||||||||
《“十三五”全国结核病防治规划》 | 5.656 | 0.059 | ||||||||||||||||
知道 | 77 (11.03) | 60 (13.64) | 9 (14.75) | 30 (9.29) | 35 (11.99) | 25 (12.69) | 56 (14.47) | |||||||||||
调查问题 | 医院等级 | 职称 | ||||||||||||||||
三级 | 二级 | 其他a | 高级 | 中级 | 初级 | 其他b | χ2值 | P值 | ||||||||||
有了解 | 308 (44.13) | 201 (45.68) | 22 (36.07) | 152 (47.06) | 146 (50.00) | 76 (38.58) | 157 (40.57) | |||||||||||
不知道 | 313 (44.84) | 179 (40.68) | 30 (49.18) | 141 (43.65) | 111 (38.01) | 96 (48.73) | 174 (44.96) | |||||||||||
《遏制结核病行动计划 (2019—2022年)》 | 4.62 | 0.099 | ||||||||||||||||
知道 | 72 (10.31) | 57 (12.96) | 7 (11.48) | 39 (12.07) | 26 (8.90) | 19 (9.64) | 52 (13.44) | |||||||||||
有了解 | 271 (38.83) | 171 (38.86) | 25 (40.98) | 125 (38.70) | 130 (44.52) | 67 (34.01) | 145 (37.47) | |||||||||||
不知道 | 355 (50.86) | 212 (48.18) | 29 (47.54) | 159 (49.23) | 136 (46.58) | 111 (56.35) | 190 (49.09) | |||||||||||
《学校结核病防控工作规范 (2017版)》 | 0.300 | 0.861 | ||||||||||||||||
知道 | 68 (9.74) | 54 (12.27) | 12 (19.67) | 30 (9.29) | 25 (8.56) | 20 (10.15) | 59 (15.25) | |||||||||||
有了解 | 270 (38.68) | 169 (38.41) | 20 (32.79) | 120 (37.15) | 117 (40.07) | 73 (37.06) | 149 (38.50) | |||||||||||
不知道 | 360 (51.58) | 217 (49.32) | 29 (47.54) | 173 (53.56) | 150 (51.37) | 104 (52.79) | 179 (46.25) | |||||||||||
《浙江省“十三五”结核病防治规划》 | 1.202 | 0.548 | ||||||||||||||||
知道 | 60 (8.60) | 53 (12.05) | 6 (9.84) | 22 (6.81) | 26 (8.90) | 15 (7.61) | 56 (14.47) | |||||||||||
有了解 | 278 (39.83) | 183 (41.59) | 24 (39.34) | 133 (41.18) | 124 (42.47) | 77 (39.09) | 151 (39.02) | |||||||||||
不知道 | 360 (51.57) | 204 (46.36) | 31 (50.82) | 168 (52.01) | 142 (48.63) | 105 (53.30) | 180 (46.51) |
调查问题 | 专业 | 职称 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
临床医生 | 护理人员 | χ2值 | P值 | 高级 | 中级 | 初级 | 其他a | χ2值 | P值 | ||
结核病筛查应该纳入中小学 新生入学体检 | 1.682 | 0.195 | 0.918 | 0.632 | |||||||
是 | 737 (90.43) | 356 (92.71) | 296 (91.64) | 261 (89.38) | 178 (90.36) | 358 (92.50) | |||||
不是 | 42(5.15) | 13(3.38) | 11(3.41) | 19(6.51) | 12(6.09) | 13(3.36) | |||||
无所谓 | 9(1.11) | 3(0.78) | 5(1.54) | 4(1.37) | 0(0.00) | 3(0.78) | |||||
不清楚 | 27(3.31) | 12(3.13) | 11(3.41) | 8(2.74) | 7(3.55) | 13(3.36) | |||||
如在校学生确诊肺结核应对密切接触者进行PPD筛查等 | 0.001 | 0.997 | 1.791 | 0.408 | |||||||
是 | 781 (95.83) | 368 (95.83) | 313 (96.90) | 277 (94.86) | 190 (96.45) | 369 (95.35) | |||||
不是 | 22(2.70) | 6(1.56) | 5(1.55) | 8(2.74) | 7(3.55) | 8(2.07) | |||||
无所谓 | 1(0.12) | 1(0.26) | 1(0.31) | 0(0.00) | 0(0.00) | 1(0.26) | |||||
不清楚 | 11(1.35) | 9(2.35) | 4(1.24) | 7(2.40) | 0(0.00) | 9(2.32) | |||||
学生结核病密切接触者应接 受预防性抗结核治疗 | 35.389 | <0.001 | 4.351 | 0.114 | |||||||
是 | 568 (69.69) | 329 (85.68) | 222 (68.73) | 196 (67.12) | 149 (75.63) | 330 (85.27) | |||||
不是 | 184(22.58) | 31(8.07) | 71(21.98) | 76(26.03) | 34(17.26) | 34(8.79) | |||||
无所谓 | 4(0.49) | 1(0.26) | 3(0.93) | 1(0.34) | 0(0.00) | 1(0.26) | |||||
不清楚 | 59(7.24) | 23(5.99) | 27(8.36) | 19(6.51) | 14(7.11) | 22(5.68) | |||||
儿科医生应积极参与学生结 核病防治工作 | 0.012 | 0.912 | 3.232 | 0.190 | |||||||
是 | 767 (94.11) | 362 (94.27) | 310 (95.97) | 273 (93.49) | 182 (92.39) | 364 (94.06) | |||||
不是 | 30(3.68) | 6(1.56) | 8(2.48) | 15(5.14) | 7(3.55) | 6(1.55) | |||||
无所谓 | 4(0.49) | 3(0.78) | 1(0.31) | 0(0.00) | 3(1.52) | 3(0.77) | |||||
不清楚 | 14(1.72) | 13(3.39) | 4(1.24) | 4(1.37) | 5(2.54) | 14(3.62) |
[1] | World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. |
[2] | 孙琳, 申阿东. 儿童结核病诊疗的现状与难点. 中国防痨杂志, 2018,40(9):912-916. doi: 10.3969/j.issn.1000-6621.2018.09.002. |
[3] | 唐神结, 李亮, 高文, 等. 中国结核病年鉴(2017). 北京: 人民卫生出版社, 2017: 12-34. |
[4] | 孙琳, 申阿东. 关注儿童结核病努力实现零死亡. 中国防痨杂志, 2018,40(9):909-911. doi: 10.3969/j.issn.1000-6621.2018.09.001 |
[5] | 黄玉, 钟节鸣, 邱晓, 等. 浙江省2005—2012年学生结核病发病趋势及特征分析. 中华疾病控制杂志, 2014,18(1):36-39. |
[6] |
Ma MJ, Yang Y, Wang HB, et al. Transmissibility of tuberculosis among school contacts: an outbreak investigation in a boarding middle school, China. Infect Genet Evol, 2015,32:148-155. doi: 10.1016/j.meegid.2015.03.001.
doi: 10.1016/j.meegid.2015.03.001 URL pmid: 25757905 |
[7] | 成君, 夏愔愔, 刘二勇, 等. 学校结核病突发疫情处置的思考. 中国防痨杂志, 2018,40(2):145-148. doi: 10.3969/j.issn.1000-6621.2018.02.006. |
[8] | 陈彬, 王晓萌, 顾华, 等. 浙江省学生肺结核患者发现延误影响因素分析. 中国学校卫生, 2013,34(11):1339-1341. doi: 10.16835/j.cnki.1000-9817.2013.11.022. |
[9] | 余刚, 崇蕾, 郑仰明, 等. 温州地区324例学龄期儿童结核病住院患儿的临床特征分析. 中华传染病杂志, 2018,36(1):40-42. doi: 10.3760/cma.j.issn.1000-6680.2018.01.011. |
[10] | 张海邻, 余刚. 儿科医师应积极参与中小学生结核病防治. 中华实用儿科临床杂志, 2019,34(9):652-655. doi: 10.3760/cma.j.issn.2095-428X.2019.09.004. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||